ACT.DEACT.DEXETRA
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank14
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P14
Within normal range
vs 5Y Ago
-2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-1.15%
2024-5.10%
20235.79%
202211.35%
20213.47%
20200.57%
20197.28%
2018-3.74%
20174.12%
20160.66%